The Predictors and Long-Term Trajectory of Poststroke Cognitive Decline
中风后认知衰退的预测因子和长期轨迹
基本信息
- 批准号:8300428
- 负责人:
- 金额:$ 15.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-01 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAgeAged, 80 and overAntihypertensive AgentsAreaAttenuatedBehaviorBehavioralBlack raceBlood PressureBlood VesselsCaringCholesterolChronic DiseaseClinicalClinical ServicesClinical TrialsCognitiveCohort StudiesCommunitiesDataData CollectionDementiaDemographic FactorsDevelopmentDevelopment PlansDiabetes MellitusDiseaseElderlyEnsureEnvironmentEpidemiologic StudiesEquilibriumFemaleFundingFutureGenderGeographic FactorGeographyGeriatricsGoalsGrantHealthHealth Care CostsHealth behaviorHealthcareHypertensionImpaired cognitionIndividualInterventionIntervention StudiesJunior PhysicianK-Series Research Career ProgramsKnowledgeLeadLocationLong-Term EffectsMeasurementMeasuresMedicalMentorsMethodsMexican AmericansMichiganMorbidity - disease rateNot Hispanic or LatinoOutcomeParticipantPathway interactionsPatientsPhysiciansPopulationPopulation DecreasesPrevalenceQuality of lifeRaceRecording of previous eventsRehabilitation therapyResearchResource AllocationResourcesRiskRisk FactorsRuralSamplingScientistSeriesStrokeStroke preventionSurvival RateSurvivorsTestingTimeUnited States National Institutes of HealthUniversitiesacute strokeage relatedaging populationblood pressure regulationcareer developmentcigarette smokingcognitive changecognitive functioncohortdemographicsdesigndisabilityeffective therapyepidemiology studyexperiencegeographic differencehigh riskimprovedmedication compliancemiddle agemortalitymultidisciplinarypopulation basedpost strokepreventprogramsprospectiveracial differenceresidenceskillssuccesstreatment adherence
项目摘要
DESCRIPTION (provided by applicant): With population aging and improved stroke survival, the rates of post stroke cognitive decline (PSCD) are increasing. PSCD is associated with adverse health outcomes, increased health costs, and poorer quality of life. There is significant variability in which stroke patients develop PSCD. Many factors likely drive this variability, including age at stroke, time from stroke onset, stroke features, socio-demographics, geography, health conditions, behaviors and medical care factors. Yet, PSCD remains poorly understood. The long-term goal of this career development award is to promote the candidate's development into a leader and independently funded physician-scientist in PSCD among older adults. The aims of this project are: 1) To determine the impact of stroke on cognitive function, both in the short-term and the long-term; 2) To determine the socio-demographic, geographic, medical, and behavioral predictors of PSCD; 3) To assess whether blood pressure or anti-hypertensive medication adherence are associated with cognitive function in stroke survivors using primary and secondary data. This project will combine data from 2 leading prospective stroke cohort studies in the US: 1) a large, geographically dispersed, race- and gender-balanced cohort of middle-aged and older adults being followed for stroke and cognitive decline and with premorbid and post stroke cognitive assessments, and 2) a population-based stroke surveillance project in a bi-ethnic community with immediate post stroke cognitive assessments. Both cohort studies have cognitive measures sensitive to PSCD and data on stroke features. This research will generate knowledge by better identifying potential mechanisms of PSCD and will assist in planning interventions to improve the care and prevention of stroke and PSCD. This research ultimately will lead to greater understanding of PSCD, better treatments, and better outcomes in older people. The candidate, Dr. Deborah Levine, who will focus her research on the growing population of stroke survivors, will pursue a mentored research plan designed to enhance her skills in the methods needed to study PSCD. A detailed career development plan will promote the candidate's development of expertise in four areas: 1) the analysis and conduct of longitudinal epidemiologic studies of older adults; 2) the measurement of cognitive outcomes; 3) patient treatment adherence and chronic illness interventions; and 4) geriatrics and stroke care. The career development plan consists of a multidisciplinary team of experienced mentors and advisors who will oversee a range of formal coursework and practical experiences in these areas to ensure the candidate's future success. Exceptional resources of a top university and a mentoring team with proven success in developing junior physician-scientists in these topic areas makes the University of Michigan an ideal environment for this project.
PUBLIC HEALTH RELEVANCE: One in three individuals will experience dementia, a stroke, or both during their lifetime. A key question for this new century is: In this era of population aging
and improved stroke survival, how can cognitive disability from stroke be reduced or delayed? To begin to confront this problem, we will establish a research program to study the epidemiology of post stroke cognitive decline and to identify risk factors that may be targets for future intervention studies. Reducing post stroke cognitive decline will be important to decrease the risk and population burden of stroke and dementia. Information from this study will better identify potential mechanisms of post stroke cognitive decline and may assist in planning interventions to reduce or prevent post stroke cognitive decline in older adults.
描述(由申请人提供):随着人口衰老和中风生存的改善,中风后认知下降(PSCD)的速度正在增加。 PSCD与不良健康结果,健康成本增加和生活质量差有关。中风患者患PSCD存在明显的差异。许多因素可能会推动这种变异性,包括中风时的年龄,中风发作的时间,中风特征,社会人口统计学,地理,健康状况,行为和医疗因素。然而,PSCD仍然很了解。该职业发展奖的长期目标是将候选人的发展促进老年人中PSCD的领导者和独立资助的医师科学家。该项目的目的是:1)确定中风对短期和长期的认知功能的影响; 2)确定PSCD的社会人口统计学,地理,医学和行为预测指标; 3)评估血压或抗高血压药物的依从性是否与使用主要和次要数据的中风幸存者中的认知功能有关。该项目将结合美国2项领先的中风队列研究的数据:1)在中期和认知下降的中年和老年人中,一项大型,地理,种族和性别均衡的中年和老年人的群体以及中风后的认知认知评估以及2)基于人口的STROKE STROKE STROKE STRIEST STRICK intrake STROKE coje tock in trouke strook coptions cognights stroke评估。两项队列研究都对PSCD敏感和中风特征的数据敏感。这项研究将通过更好地识别PSCD的潜在机制来产生知识,并将有助于计划干预措施,以改善中风和PSCD的护理和预防。这项研究最终将导致对PSCD,更好的治疗方法以及老年人的更好结果。 候选人Deborah Levine博士将把研究重点放在中风幸存者不断增长的人群上,他将遵循一项旨在提高她在研究PSCD所需方法的技能的指导研究计划。详细的职业发展计划将促进候选人在四个领域的专业知识的发展:1)对老年人的纵向流行病学研究的分析和进行; 2)认知结果的测量; 3)患者治疗依从性和慢性疾病干预措施; 4)老年医学和中风护理。职业发展计划由一个由经验丰富的导师和顾问组成的跨学科团队组成,他们将在这些领域监督一系列正式的课程和实践经验,以确保候选人未来的成功。顶尖大学的卓越资源和在这些主题领域发展初级医师科学家方面取得成功取得成功的指导团队使密歇根大学成为该项目的理想环境。
公共卫生相关性:三分之一的人会在一生中经历痴呆症,中风或两者兼而有之。这个新世纪的一个关键问题是:在这个人口衰老的时代
并改善了中风的存活情况,如何减少或延迟中风的认知障碍?为了开始面对这个问题,我们将建立一个研究计划,以研究中风后认知下降的流行病学,并确定可能是未来干预研究目标的危险因素。减少中风后认知下降对于减轻中风和痴呆症的风险和人口负担至关重要。这项研究的信息将更好地确定中风后认知下降的潜在机制,并可能有助于计划干预措施,以减少或预防老年人中风后认知下降。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Deborah Levine其他文献
Deborah Levine的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Deborah Levine', 18)}}的其他基金
The Effect of Vascular Risk Factors on Risk of Alzheimer's Disease and Related Dementias after Stroke (STROKE COG)
血管危险因素对中风后阿尔茨海默病和相关痴呆症 (STROKE COG) 风险的影响
- 批准号:
10030919 - 财政年份:2020
- 资助金额:
$ 15.93万 - 项目类别:
The Effect of Lower Blood Pressure over the Life Course on Late-life Cognition in Blacks, Hispanics, and Whites (BP-COG)
一生中较低血压对黑人、西班牙裔和白人晚年认知的影响 (BP-COG)
- 批准号:
9367047 - 财政年份:2017
- 资助金额:
$ 15.93万 - 项目类别:
The Effect of Lower Blood Pressure over the Life Course on Late-life Cognition in Blacks, Hispanics, and Whites (BP-COG)
一生中较低血压对黑人、西班牙裔和白人晚年认知的影响 (BP-COG)
- 批准号:
10198048 - 财政年份:2017
- 资助金额:
$ 15.93万 - 项目类别:
Decision Making for Cardiovascular Therapy in Adults with Mild Cognitive Impairment
轻度认知障碍成人心血管治疗的决策
- 批准号:
9519775 - 财政年份:2016
- 资助金额:
$ 15.93万 - 项目类别:
Decision Making for Cardiovascular Therapy in Adults with Mild Cognitive Impairment
轻度认知障碍成人心血管治疗的决策
- 批准号:
9926790 - 财政年份:2016
- 资助金额:
$ 15.93万 - 项目类别:
Decision Making for Cardiovascular Therapy in Adults with Mild Cognitive Impairment
轻度认知障碍成人心血管治疗的决策
- 批准号:
9346592 - 财政年份:2016
- 资助金额:
$ 15.93万 - 项目类别:
The Predictors and Long-Term Trajectory of Poststroke Cognitive Decline
中风后认知衰退的预测因子和长期轨迹
- 批准号:
8721822 - 财政年份:2012
- 资助金额:
$ 15.93万 - 项目类别:
The Predictors and Long-Term Trajectory of Poststroke Cognitive Decline
中风后认知衰退的预测因素和长期轨迹
- 批准号:
8850769 - 财政年份:2012
- 资助金额:
$ 15.93万 - 项目类别:
The Predictors and Long-Term Trajectory of Poststroke Cognitive Decline
中风后认知衰退的预测因子和长期轨迹
- 批准号:
8531124 - 财政年份:2012
- 资助金额:
$ 15.93万 - 项目类别:
相似国自然基金
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
- 批准号:82300679
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
- 批准号:82301784
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Vision Impairment in the National Health and Aging Trends Study: Epidemiology, Social Determinants of Health, and Adverse Late Life Outcomes
国家健康和老龄化趋势研究中的视力障碍:流行病学、健康的社会决定因素和不良的晚年结局
- 批准号:
10730418 - 财政年份:2023
- 资助金额:
$ 15.93万 - 项目类别:
Driving the Progeny of Olfactory HBC Stem Cells toward Neuronal Differentiation
驱动嗅觉 HBC 干细胞后代向神经元分化
- 批准号:
10527167 - 财政年份:2022
- 资助金额:
$ 15.93万 - 项目类别:
Driving the Progeny of Olfactory HBC Stem Cells toward Neuronal Differentiation
驱动嗅觉 HBC 干细胞后代向神经元分化
- 批准号:
10642890 - 财政年份:2022
- 资助金额:
$ 15.93万 - 项目类别:
Prognostic Implications of Home-Based Blood Pressure Monitoring in Older Adults
老年人家庭血压监测的预后意义
- 批准号:
10631185 - 财政年份:2021
- 资助金额:
$ 15.93万 - 项目类别:
Immunogenicity of recombinant zoster vaccine in Rheumatoid arthritis patients
重组带状疱疹疫苗对类风湿关节炎患者的免疫原性
- 批准号:
10663064 - 财政年份:2021
- 资助金额:
$ 15.93万 - 项目类别: